Verastem reported $-0.48 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Alaunos Therapeutics USD -0.52 0.02 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
Curis USD 1.23 3.26 Dec/2025
Cytokinetics USD -1.67 0.17 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
Laboratory Of America USD 4.25 0.18 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
TG Therapeutics USD 0.12 0.02 Mar/2026
Verastem USD -0.48 0.12 Dec/2025